A randomized pilot study of tenofovir/emtricitabine (TDF/FTC) + boosted atazanavir (ATV/r) vs. raltegravir (RAL BID) + ATV/r vs. RAL BID + ATV BID. - Cohen, C; Green, J; Olivet, H; Khanlou, H; Burman, W; Corales, R; Pierone, G; DeJesus, E; Vanig, T; Tribble, M; Sweet, D; Appelbaum, J; et al. (Journal of the International AIDS Society, 2012)